Select Committee on Science and Technology Minutes of Evidence


Annex 1

Table 1


Table 2

RISK GROUPS TARGETED FOR FLU VACCINE
—  Persons over the age of 65 years

—  Persons living in residential institutions
    Also, patients below 65 years of age with:

—  Diabetes
—  Asthma
—  Renal Failure
—  Immune deficiencies
—  Chronic Obstructive Pulmonary Disease
—  Chronic Heart Disease


Table 3

VARIATIONS IN IMPLEMENTATION OF NATIONAL FLU POLICY BY REGION
Payment received by GP in ENGLAND Payment received by GP in

WALES
Payment received by GP in SCOTLAND Payment received by GP in NORTHERN IRELAND
Over 65sItem of service fee (£6.80 per patient)
Profit and administration
Item of service fees (£6.80 per patient)
Profit and administration
Assuming 50 per cent coverage
Item of service fee of £7.88 per patient
Item of service fees (£6.80 per patient)
Additional payment for data collection (£1.75 per patient)
At risk groupsProfit and administration only Profit and administration fees
£4.70 per patient item of service fee
NilItem of service fee of £6.80 per patient


Table 4

COST-EFFECTIVENESS OF INFLUENZA AND PNEUMOCOCCAL VACCINATION COMPARED WITH OTHER INTERVENTIONS USED AMONG OLDER PERSONS*
InterventionCost per Life-year Gained ($)
Influenza vaccination, ~ 65 years1,300
Pneumococcal vaccination, ~ 65 years1,800
Mammogram, 50-65 years q 3 years2,700
Papanicolaou test, ~ 65 years, q 3 years 2,800
Coronary angioplasty, men 55 years, severe angina 5,300
Coronary bypass surgery, men 55 years, left main disease 5,600
Hypertension screening, 60 years, asymptomatic 11,000
Cholesterol 180 mg/dL, men ~ 60 years, diet only 12,000
Estrogen-progestin, ~ 50 years, symptomatic 15,000
*Adapted from Tengs T O, Adams M E, Pliskin J S, et al. Five-hundred life-saving interventions and their cost-effectiveness. Risk Analysis 1995; 15:369-90




 
previous page contents next page

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2003